Pathophysiology of insulin-regulated renal blood flow and sodium excretion
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
批准号:
10206134
负责人:
Michael W. Brands
金额:
$37.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2023-06-30
关键词:
AcuteAddressBlood PressureBolus InfusionChronicClosure by clampConsciousDataDiabetes MellitusDietDiseaseElementsExcretory functionFunctional disorderGlucoseHyperinsulinismHypertensionImpairmentInsulinIntakeKidneyLinkLiteratureMeasurementMediatingMetabolicMetabolic syndromeNitric OxideObesityPathologyPhysiologicalPhysiologyPlasmaRattusRecoveryRegulationRenal Blood FlowRoleSodiumSodium ChlorideSucroseTelemetryTestingThromboxanesTranslatingTubular formationVasoconstrictor AgentsVasodilationepithelial Na+ channelexperimental studyfallsinstrumentinsulin regulationnovelpressurepreventresponseurinaryvasoconstrictionwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Impaired regulation of renal blood flow (RBF) is recognized as a critical element in the pathologies of diabetes
and metabolic syndrome through effects on glomerular pressure, GFR, and urinary sodium excretion (UNaV).
The mechanism for impaired RBF regulation in these conditions is not known. We have evidence for a novel
physiological effect of insulin on RBF that may translate to mechanisms for pathophysiological RBF impact.
Our data suggest that preventing excess sodium loss after meals is the physiological function of insulin-
regulated UNaV. This is not due solely to tubular sodium reabsorption, as the literature would predict. We
show that insulin also exerts renal vasoconstrictor tone after meals, possibly via thromboxane (TXA2), that
limits the degree of meal-induced renal vasodilation. Impairment, of that physiological function should cause
excessive renal vasodilation after meals, causing renal salt wasting and potential long-term implications on the
progression of CKD. Exaggeration of this physiological function should cause overt renal vasoconstriction,
sodium retention, and hypertension if sustained. Additional data show that blocking the protective role of
nitric oxide (NO) enables high-sucrose diet to cause hypertension, which we can prevent by blocking
hyperinsulinemia. We will test the central hypothesis that: The physiological, sodium-conserving effect of
insulin is mediated in part by a post-meal renal vasoconstrictor influence that limits the degree of meal-induced
renal vasodilation. Counterbalancing input from nitric oxide is required to prevent overt renal vasoconstriction
and hypertension. The specific aims will test whether:
Aim 1: The physiological, sodium-conserving effect of insulin is mediated in part by a post-meal renal
vasoconstrictor influence. The experiments will test the hypotheses that: a. Preventing the meal-induced
increase in plasma insulin will cause greater and more sustained increases in RBF and greater UNaV than
occurs in normal control rats. b. The insulin-dependent renal vasoconstrictor influence requires TXA2. c. Under
conditions of background NOS inhibition, glucose bolus will cause overall renal vasoconstriction and amplified
sodium retention. d. ENaC mediates the tubular reabsorption component of the acute sodium-conserving
effect of insulin. Aim 2: Impaired NO synthesis causes insulin-dependent renal vasoconstriction and
hypertension during high-sucrose intake. Experiments test the hypotheses that: a. NOS inhibition will enable
chronic high-sucrose intake to cause hypertension (DSI telemetry, 24 hr/day). b. Blocking hyperinsulinemia will
prevent the hypertensive response to high-sucrose intake. Restoring only intra-renal hyperinsulinemia
restores the hypertension response. c. TXA2 synthase inhibition will prevent the hypertensive effect of chronic
high-sucrose intake.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
-
批准号:10440320
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2020
-
负责人:Michael W. Brands
-
依托单位:
Animals and Instrumentation Core
-
批准号:10094226
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2017
-
负责人:Michael W. Brands
-
依托单位:
Damage-Associated Molecular Patterns in Hypertension
-
批准号:10094220
-
项目类别:
-
资助金额:$188.85万
-
财政年份:2017
-
负责人:Michael W. Brands
-
依托单位:
Peach State Bridges to the Doctorate
-
批准号:9750021
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2015
-
负责人:Michael W. Brands
-
依托单位:
Peach State Bridges to the Doctorate
-
批准号:8934722
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2015
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7433775
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2007
-
负责人:Michael W. Brands
-
依托单位:
Core--Animal
-
批准号:7433780
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2007
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:7228248
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2006
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7228243
-
项目类别:
-
资助金额:$16.91万
-
财政年份:2006
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:7063187
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2005
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7063182
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2005
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:6853166
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:7008871
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:6719792
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:6845400
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:6853177
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:7173311
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
CARDIOVASCULAR AND RENAL DYSFUNCTION IN EARLY DIABETES
-
批准号:6409618
-
项目类别:
-
资助金额:$6.27万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
Mechanisms for Cardiovascular Control Early in Diabetes
-
批准号:7037566
-
项目类别:
-
资助金额:$23.93万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
Mechanisms for Cardiovascular Control Early in Diabetes
-
批准号:7848811
-
项目类别:
-
资助金额:$33.08万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
海外基金